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Transcription factors NF-B1 and c-Rel, individually dispensable
during embryogenesis, serve similar, yet distinct, roles in the
function of mature hemopoietic cells. Redundancy among Rel
NF-B family members prompted an examination of the combined
roles of c-Rel and NF-B1 by using mice that lack both proteins.
Embryonic development and the maturation of hemopoietic pro-
genitors were unaffected in nfkb1/c-rel/mice. Peripheral T cell
populations developed normally, but follicular, marginal zone, and
CD5 peritoneal B cell populations all were reduced. In culture, a
failure of mitogen-stimulated nfkb1/c-rel/ B cells to proliferate
was caused by a cell cycle defect in early G1 that prevented growth.
In vivo, defects in humoral immunity and splenic architecture seen
in nfkb1/ and c-rel/ mice were exacerbated in the double
mutant mice. These findings demonstrate that in the B lineage
overlapping roles for NF-B1 and c-Rel appear to be restricted to
regulating the activation and function of mature cells.
RelNF-B transcription factors comprise a group of dimericproteins assembled from a family of related subunits. The
mammalian polypeptides (NF-B1, NF-B2, RelA, RelB, and
c-Rel) share a conserved amino terminus (Rel homology do-
main, RHD) that encompasses sequences essential for DNA
binding, dimerization, and nuclear localization (1). c-Rel, RelA,
and RelB possess carboxyl-terminal transcriptional transactiva-
tion domains, whereas the cleaved forms of NF-B1 and NF-
B2, which only comprise the RHD, function as homodimeric
transcriptional repressors or modulators of transactivating dimer
partners (1, 2). RelNF-B factors exist mainly in the cytoplasm
as inactive complexes with IB proteins (1, 2) and in response to
diverse signals are translocated to the nucleus as a result of IKK
phosphorylation-induced IB degradation (3). In the nucleus,
RelNF-B factors control transcription by binding specific
sequences (B elements) found within the regulatory regions of
many cellular genes (1, 2).
In hemopoietic cells, essential roles served by individual
RelNF-B proteins have been revealed in mutant mice gener-
ated by gene targeting (4). In the absence of c-Rel, RelA,
NF-B1, or NF-B2, progenitor differentiation appears normal
(4), but the activation and function of mature cells are impaired.
For lymphocytes, this includes proliferative defects associated
with division and survival and impaired isotype switching and
cytokine expression (4), which collectively affect cell-mediated
and humoral immunity (2, 4, 5). In single mutant mice, over-
lapping activities among RelNF-B proteins can lead to phe-
notypic masking or diminished severity of the defects (4, 5). This
process is best illustrated in the B cell lineage, where different
combinations of RelNF-B null mutations result in novel
defects at distinct developmental junctures. In the absence of
NF-B1 and RelA, B220 precursors are absent (6). In
nfkb1/nfkb2/ mice, B cell development is blocked at the
immature IgMhiIgDlo stage (7), whereas a loss of c-Rel and RelA
results in differentiation being stalled at the transitional stage
(IgMhiIgDhi), a point preceding entry into the mature peripheral
B cell pool (8). Here we examined what effects the combined loss
of c-Rel and NF-B1 has on hemopoiesis, in particular B cell
development and function. Whereas nfkb1/c-rel/ hemopoi-
etic stem cell differentiation appeared normal, humoral immu-
nity was severely impaired, probably in part a result of profound
B cell activation defects that include a failure of B cells to
undergo normal growth.
Materials and Methods
Mice. Mice used in this study were aged between 6 and 10 weeks.
nfkb1/c-rel/ mice were generated by intercrossing nfkb1/
(9) and c-rel/ (10) mice previously backcrossed eight and 10
times, respectively with the C57BL6 strain. Wild-type and null
alleles for c-rel and nfkb1 were discriminated by PCR of tail
biopsy DNA samples (8).
Bone Marrow Cultures. Bone marrow agar cultures were per-
formed as described (10) by using murine growth factors gran-
ulocyte-macrophage colony-stimulating factor, IL-3 (each at 10
ngml), and stem cell factor (100 ngml). Cultures were incu-
bated at 37°C for 7 days, fixed, and stained, and colonies were
identified and enumerated.
Immunofluorescence Staining And Flow Cytometry. Dispersed cells
from the thymus, spleen, bone marrow, lymph nodes, or peri-
toneum were used for two- and three-color immunofluorescent
staining. For two-color stains, T cells were visualized with
FITC-conjugated anti-CD4 and R-phycoerythrin (PE)-
conjugated anti-CD8 (Caltag, South San Francisco, CA), and B
cells were stained with FITC-conjugated B220 and biotinylated
anti-IgM or anti-CD5 as described (11, 12). For three-color
stains of splenic B lymphocytes, cells were incubated with
PE-conjugated anti-IgM, FITC-conjugated anti-CD23, and bio-
tinylated anti-CD21. Biotinylated antibodies were revealed by
secondary staining with Streptavidin-Tricolor (Caltag). Be-
tween 5,000 and 10,000 viable cells were analyzed by using a
FACScan flow cytometer (Becton Dickinson).
Immunization and ELISA Assays. Mice were immunized with the
T-dependent antigen nitrophenyl (NP) coupled to keyhole lim-
Abbreviations: NP, nitrophenyl; KLH, keyhole limpet hemocyanin; LPS, lipoplysaccharide;
PNA, peanut agglutanin; PI, propidium iodide.
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pet hemocyanin (KLH) (NPKLH conjugation ratio of 17:1) by
i.p. injection with 100 g of immunogen precipitated in alum.
Serum samples were collected before and 21 days after immu-
nization. NP-specific Ig levels were determined by ELISA (10)
using NP17-BSA as a capture agent and goat anti-mouse isotype-
specific sera conjugated to horseradish peroxidase as the reveal-
ing reagent. Absolute levels of each isotype were determined by
using purified myeloma protein standards.
Lymphocyte Activation in Tissue Culture. Small resting B cells
purified to95% purity by negative sorting (11) were stimulated
in culture at an input of 3  105ml in 100 l with lipoplysac-
charide (LPS) (20 gml), goat anti-mouse IgM (Fab)2 frag-
ments (Jackson ImmunoResearch, 20gml), rat anti-mouse RP
mAb (1 gml), a mitogenic antibody specific for the B cell
surface protein RP (10), or recombinant IL-4 (100 unitsml).
Proliferation was measured by pulsing cultures with 0.5 Ci
[3H]thymidine (Amersham Pharmacia) for 6 h and measuring
incorporated radioactivity by scintillation counting.
Apoptosis, Cell Cycle, and Cell Turnover Analysis. Viability and cell
division in mitogen-stimulated B cell cultures were determined
by monitoring cellular DNA content with propidium iodide (PI)
staining (11). For cell cycle analysis, cells were fixed (8 h at
4°C) in 70% ethanol, treated with 0.5 gml of DNase-free
RNase A for 20 min at room temperature, and stained with 69
M PI in 0.1 M sodium citrate (pH 7.4) for 30 min at 4°C. Flow
cytometric analysis (10,000 cellssample) was performed on a
FACScan and cell cycle distributions were determined with the
CELLFIT program (Becton Dickinson). Cell turnover in mice was
determined by labeling proliferating cells with BrdUrd as de-
scribed (11). Incorporated BrdUrd was detected in immature
(sIgMhiIgDlo) and mature (sIgMloIgDhi) splenic B cells by flow
cytometry using the FITC-labeled BU-1 mAb (Becton Dickin-
son) in conjunction with anti-IgM and anti-IgD-specific
antibodies.
PCR Detection of Germ-Line Ig CH Transcripts. Total RNA isolated
from B cell cultures was used as a template for cDNA synthesis
followed by 30 cycles of PCR amplification as described (8).
Oligonucleotides used for PCR amplification of germ-line 3,
1, , , and  actin transcripts have been described (13). PCR
samples were fractionated on 1.5% agarose gels, with the identity
of PCR products confirmed by Southern blotting.
Staining of Germinal Centers in Tissue Sections. Splenic sections
were stained with horseradish peroxidase-labeled anti-B220
(6B2) and biotinylated PNA (Vector Laboratories). Bound PNA
was visualized by using streptavidin-alkaline phosphatase fol-
lowed by enzymatic detection with naphthol AS-MX phosphate
(Sigma), Fast blue BB Salt (Sigma), and levamisole (Sigma) at
0.125, 0.25, and 0.25 mgml, respectively in 0.1 M TrisHCl, pH
8.5. Bound anti-B220 was visualized by staining with anti-rat Ig
antibodies coupled to horseradish peroxidase followed by incu-
bation with the horseradish peroxidase substrate.
Results
Embryonic Development and Hemopoiesis Are Normal in nfkb1/
c-rel/ Mice. To determine whether the combined activity of
NF-B1 and c-Rel was essential for mouse development,
nfkb1/c-rel/ mice were intercrossed. nfkb1/c-rel/ off-
spring, born at a frequency of 25%, reached maturity without
an increased incidence of death, indicating that both transcrip-
tion factors were dispensable for fetal and neonatal develop-
ment. Adults displayed no morphological or histological abnor-
malities, were fertile, and exhibited normal behavior.
Because the loss of NF-B1 or c-Rel specifically aff licted the
function of mature hemopoietic cells (4, 5, 9, 10), we focused our
analysis on these lineages in nfkb1/c-rel/ mice. Mature
hemopoietic cells from all lineages were observed in the bone
marrow, spleen, and blood of naı¨ve nfkb1/c-rel/ mice, with
the number of erythrocytes, platelets, granulocytes, eosinophils,
and macrophages falling within normal ranges (results not
shown). The finding that hemopoiesis in nfkb1/c-rel/ mice
appeared to be unaffected was supported by bone marrow
colony-forming cell assays, which demonstrated that the fre-
quency of nfkb1/c-rel/ hemopoietic progenitors and their
differentiative capacity in culture was normal (see Table 2, which
is published as supporting information on the PNAS web site,
www.pnas.org).
A survey of thymic and splenic lymphoid populations in
nfkb1/c-rel/ mice by using flow cytometric analysis of cells
stained with labeled mAbs specific for cell surface markers is
summarized in Table 1. All major thymocyte subpopulations
(CD4CD8, CD4CD8, CD4CD8, CD4CD8) were
present in normal numbers, as were the CD4 and CD8 splenic
T cell populations. Thus, T cell development and selection did
not appear to be affected. In contrast, various mature
nfkb1/c-rel/ B cell populations were reduced. In the spleen,
follicular B cell numbers were marginally diminished compared
with that of wild-type and single mutant mice. Although follic-
ular B cells comprise a lower proportion of the cellular popu-
lation in nfkb1/ spleens compared with wild-type and c-rel/
mice, the increased splenic cellularity in nfkb1/ mice (mainly
caused by elevated granulocyte levels, unpublished results)
meant that absolute follicular B cell numbers were normal.
Marginal zone B cells, reduced in nfkb1/ mice (14), were
reduced to a similar extent in nfkb1/c-rel/ animals. The
number of CD5 peritoneal B cells also varied in the different
Rel/NF-B mutants (Fig. 1), with 2- and 6-fold reductions,
respectively, in nfkb1/ and nfkb1/c-rel/ mice.
Various studies have highlighted crucial antiapoptotic roles
Table 1. The proportion of the different T and B cell populations within the thymus and spleen of wild-type, nfkb1/, c-rel/, and
nfkb1/ c-rel/ mice of 8–10 weeks of age were determined by flow cytometry using the B- and T cell-specific mAbs as described
in Materials and Methods
Genotype
Spleen
Thymus T cells, % B cells, %
Cellularity,
107
CD4CD8,
%
CD4CD8,
%
CD4CD8,
%
CD4CD8,
%
Cellularity,
106
CD4CD8,
%
CD4CD8,
%
Marginal
zone Follicular
Wild type 16  2 3  0.4 7  1 2  0.3 88  4 70  21 21  2 16  2 4.1  0.3 46  7
nfkb1/ 17  1 2  0.3 8  2 2  0.3 89  4 92  17 13  3 11  3 1.7  0.3 37  6
c-rel/ 15  2 2  0.4 6  1 3  0.2 86  4 76  18 19  2 11  1 3.7  0.7 46  9
nfkb1/ c-rel/ 17  2 3  0.2 6  1 2  0.3 87  5 77  28 18  3 13  2 1.7  0.6 29  7
The mean  SD were based upon the analysis of six mice of each genotype.
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for RelNF-B in mature B cells (15). NF-B1 promotes the
survival of resting splenic B cells (11), whereas c-Rel prevents
apoptosis in activated B cells by up-regulating bcl-2-like prosur-
vival gene expression (16, 17). Because the death of quiescent
nfkb1/ follicular B cells is abnormally high in culture and their
turnover is increased in vivo (11), these parameters were exam-
ined in nfkb1/c-rel/ mice to determine whether the dimin-
ished follicular B cell population reflected levels of apoptosis
greater than that observed in nfkb1/ animals. These results
(Fig. 2) show that in the combined absence of NF-B1 and c-Rel,
B cell turnover in vivo measured by BrdUrd incorporation (Fig.
2A) and spontaneous cell death in culture (Fig. 2B) were
equivalent to that observed for nfkb1/ mice. This finding
suggests that the reduction in follicular B cells seen in
nfkb1/c-rel/ mice is not caused by a survival defect.
Mitogens Fail to Induce nfkb1/c-rel/ B Cell Proliferation. NF-B1
and c-Rel are critical for B cell proliferation (5, 15), with
nfkb1/ and c-rel/ B cells exhibiting similar, yet distinct,
proliferative defects that arise from impaired cell cycle progres-
sion and increased apoptosis (5, 11). nfkb1/ B cells are
hyporesponsive to LPS but respond normally to anti-IgM anti-
bodies (9), whereas c-rel/ cells fail to divide in response to a
variety of single mitogenic signals (10, 11). Because the c-rel/
B cell proliferative defect is overcome by certain combined
stimuli (11), which individually are ineffective, the ability to
bypass the defect in c-rel/ B cells may reflect complementary
roles served by other family members such as NF-B1. This
model was tested by examining the proliferative response of
nfkb1/c-rel/B cells (Fig. 3A). Whereas nfkb1/ and c-rel/
B cell responses to single and multiple mitogens were as expected
(9–11), dual stimuli, such as anti-IgMLPS or anti-RPLPS that
overcame the defect in c-rel/ cells, induced only a weak
response by nfkb1/c-rel/ B cells. The failure of nfkb1/c-
rel/ B cells to proliferate in response to these and other
mitogenic signals, including CD40 ligand and IL-4 (results not
shown), coincided with a low frequency of cells in the S and
G2M phases of the cell cycle after 72 h stimulation (Fig. 3B),
plus a marked increase in apoptosis compared with single mutant
B cells (Fig. 3C). The increased severity of the nfkb1/c-rel/
proliferative defect was not caused by reduced survival, as bcl-2
transgene expression inhibited activation-induced apoptosis, but
failed to enhance nfkb1/c-rel/ B cell division (results not
shown).
NF-B1 and c-Rel Cooperate to Regulate B Cell Growth. The failure
of nfkb1/c-rel/ B cells to respond to any mitogens indicated
that the proliferative defect may be distinct from that aff licting
nfkb1/ and c-rel/ B cells. In the single mutant B cells, the cell
cycle block occurs late in G1, after an increase in cell size (11).
To test whether the nfkb1/c-rel/ defect occurs earlier in G1,
entry of stimulated cells into the cell cycle, as measured by cell
size was assessed by using flow cytometry. Forward scatter
profiles of untreated and stimulated B cells are shown in Fig. 4.
Stimulated nfkb1/ B cells increase in size normally, whereas
c-rel/ B cells form blasts with slightly delayed kinetics. Acti-
vated nfkb1/c-rel/ B cells, however, fail to undergo enlarge-
ment, even after 72 h. The inability to form blasts was accom-
panied by a failure to up-regulate expression of the cell surface
markers CD25, B7.1, and B7.2 (results not shown), which
normally increase within 24 h of mitogenic activation (18). These
results indicate that nfkb1/c-rel/ B cell proliferation is
blocked in early G1 at a point preceding growth.
The Combined Loss of NF-B1 and c-Rel Causes Severe Humoral
Immune Defects. To determine whether the varying severity of
mitogen-associated activation defects for nfkb1/, c-rel/, and
nfkb1/c-rel/ B cells in culture were manifest to the same
Fig. 1. The peritoneal CD5 B cell population is diminished in nfkb1/
c-rel/ mice. Cells isolated from the peritoneal cavity of wild-type, c-rel/,
nfkb1/, and nfkb1/ c-rel/ mice were stained with mAbs for B220 and
CD5, then examined by flow cytometry. A typical series of staining profiles is
shown, with the proportion of CD5 B cells (boxed region) observed in mice
of each genotype expressed as a percentage of the total peritoneal cell
population.
Fig. 2. Absence of c-Rel does not enhance spontaneous death in culture or
turnover of nfkb1/ B cells in vivo. (A) Splenic B cell turnover in vivo.
Splenocytes isolated from wild-type and mutant mice fed BrdUrd over 5 days
were subjected to three-color immunofluorescent staining and flow cytom-
etry to determine the fraction of immature (sIgMhiIgDlo) and mature
(sIgMloIgDhi) B cells incorporating BrdUrd. The kinetics of BrdUrd incorpora-
tion by immature and mature wild-type (E), nfkb1/ (‚), c-rel/ ({), and
nfkb1/c-rel/ () B cells over a 5-day time course are summarized. Values
represent the mean SD from four mice per genotype at each time point; the
data are representative of two experiments. (B) Survival of quiescent B cells in
culture. Resting splenic B cells from wild-type (E), nfkb1/ (‚), c-rel/ ({),
and nfkb1/c-rel/ () mice were cultured in DME/10% FCS without mito-
gens or cytokines for 72 h. At 24-h intervals, the frequency of dead cells was
determined by flow cytometric analysis of PI-stained cells. At the start of the
experiments,99% of all cells were viable. The data represent the mean SD
of five experiments.
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degree in vivo, humoral immune responses in the mutant mice
were compared. In naı¨ve animals, most serum Igs, which are
lower than normal in the single mutants (9, 10), were further
reduced in nfkb1/c-rel/ mice (Fig. 5A), a 30-fold drop in
serum IgM compared with relatively normal IgM levels
in c-rel/ and nfkb1/ mice being the most striking change. In
response to immunization with NP-KLH, for which an IgG1
response normally predominates (19), antigen-specific IgG1,
although reduced in the single mutants as reported (9, 10), was
undetectable in nfkb1/c-rel/ mice 21 days postimmunization
(Fig. 5B) and at later times (data not shown).
Poor antibody production by nfkb1/c-rel/ mice could be
caused in part by compound defects in isotype switching that
result from impaired antigen and cytokine-induced germ-line CH
gene transcription in the absence of NF-B1 (13) or c-Rel (15).
This was examined in culture by measuring mitogen plus cyto-
kine-induced germ-line CH gene expression using semiquanti-
tative reverse transcription–PCR (Fig. 5C). Because CH RNA
levels were measured within 6 h of stimulation, impaired pro-
liferation and survival should not impact RNA levels. In contrast
to restricted defects in CH gene expression seen in nfkb1/
(C3 and C RNAs) and c-rel/ (C1and C RNAs) B cells, all
germ-line CH RNAs examined were undetectable in activated
nfkb1/c-rel/ B cells.
The effect an absence of NF-B1 and c-Rel had on germinal
centers, areas within secondary lymphoid organs where intense
B cell proliferation and antigen receptor affinity maturation
occurs during an immune response, was also examined. Splenic
cryosections from normal and mutant mice immunized with
NP-KLH were stained with biotinylated peanut agglutanin
(PNA) (Fig. 6), with high-level binding corresponding to ger-
minal center B cells. Whereas normal spleens display large
strongly staining PNA regions within B cell follicles, germinal
center formation was impaired or absent in the mutant mice.
Least affected were the nfkb1/ mice; despite a reduction in the
number and size of the germinal centers, PNAhi staining cells
were present. In the absence of c-Rel, even fewer clearly
demarcated PNA germinal centers were present, with those
found being small in size and irregular in shape. In nfkb1/
c-rel/ mice, no PNA cells were observed in the B cell follicles.
These findings indicate that either the generation or mainte-
nance of germinal center B cells depends on the activity of
NF-B1 and c-Rel.
Discussion
In addition to unique roles ascribed to each RelNF-B subunit,
some functional overlap among these transcription factors has
meant mutant mice lacking different combinations of proteins
are necessary to determine the complete spectrum of functions
each family member serves. Here we show that NF-B1 and
c-Rel, despite being coexpressed in various embryonic tissues as
early as embryonic day 12.5 (20), are not essential for fetal or
neonatal development. Relatively normal development of all
hemopoietic lineages in nfkb1/c-rel/ mice was unexpected
given the coexpression of NF-B1 and c-Rel in hemopoietic
progenitors (20) and the finding that different aspects of hemo-
poietic differentiation are disrupted in mice lacking other com-
binations of RelNF-B proteins (4).
Fig. 3. nfkb1/c-rel/ B cells fail to proliferate in response to mitogenic stimulation. (A) B cell proliferative responses. Purified resting wild-type (filled bars),
nfkb1/ (hatched bars), c-rel/ (empty bars), or c-rel/nfkb1/ (stippled bars) splenic B cells were stimulated for 72 h with optimal concentrations of anti-IgM
(Fab)2 antibodies, anti-RP antibodies, LPS, anti-IgM antibodies plus LPS, or anti-RP antibodies plus LPS. Proliferation was measured by [3H]thymidine
incorporation. (B) Cell cycle analysis. The fraction of viable cells of each genotype (identification code as above) in the S, G2, or M phases of the cell cycle after
stimulation for 72 h with the indicated mitogens was determined by flow cytometric analysis of permeabilized cells stained with PI. Before stimulation, more
than 99% of resting B cells were viable and 1% of cells had entered the cell cycle. (C) Cell death. The frequency of apoptotic cells (genotypic code as for A)
expressed as a proportion of the total cell number after 72 h of mitogen stimulation was determined by flow cytometric analysis of permeablized cells stained
with PI. Cells with a DNA content 2n were deemed to be apoptotic. All results shown represent the mean  SD from five experiments.
Fig. 4. A combined absence of NF-B1 and c-Rel prevents mitogen-induced
B cell growth. Normal, c-rel/, nfkb1/, and nfkb1/c-rel/ splenocytes
stimulated in culture with anti-RP antibodies plus LPS for 72 h were stained at
24-h intervals with biotinylated B220, then examined by flow cytometry.
Forward light scatter profiles (x axis: linear scale) are a measure of cell size. The
data shown were electronically gated to exclude dead cells and are represen-
tative of three experiments. Similar results were obtained by using different
stimuli (results not shown).
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In the B lineage, NF-B1RelA and RelAc-Rel are the
predominant heterodimeric complexes in progenitors (21, 22).
During the pre-B to B cell transition, up-regulation of NF-B1
and c-Rel (21, 23, 24) leads to a shift in the relative abundance
of different RelNF-B proteins, with NF-B1c-Rel and NF-
B1 homodimers emerging as the major complexes found in
mature B cells. The importance of NF-B1RelA and NF-B1
c-Rel in normal immature and mature B cells, respectively, is
supported by the phenotypes resulting from the loss of these
RelNF-B combinations. Whereas NF-B1 and RelA are es-
sential for the development or survival of B cell progenitors (6),
loss of NF-B1 and c-Rel does not disrupt lymphopoiesis, but
instead affects activation-associated functions in mature B cells.
Together with roles for NF-B1NF-B2 and c-RelRelA in
promoting the development and survival of immature and
transitional B cells, respectively (7, 8), these findings indicate
that different RelNF-B complexes serve essential, nonredun-
dant functions at distinct checkpoints throughout B cell ontogeny
(Fig. 7).
The basis of the selective reduction of various mature B cell
populations in nfkb1/c-rel/ mice remains to be determined.
Whereas NF-B1 promotes the survival of quiescent follicular B
cells in culture, steady-state numbers are normal in vivo (11).
Because both survival in culture and turnover in vivo is equiv-
alent for nfkb1/ and nfkb1/c-rel/ follicular B cells, the
reduction in nfkb1/c-rel/ follicular B cell numbers does not
appear to involve increased apoptosis. One possibility is im-
paired homing of this population in nfkb1/c-rel/ mice. This
notion is given credence by the finding that B cell homing is
abnormal in nfkb1/nfkb2/ mice caused by reduced expres-
sion of the BLR1 B cell chemokine receptor (25). Although
survival defects cannot be ruled out as an explanation for the
reduction in nfkb1/c-rel/ CD5 B cells, the observation that
CD5 B cells often are diminished in mice that exhibit B cell
proliferative defects (26) is consistent with the findings pre-
sented here on the combined roles of NF-B1 and c-Rel in B cell
activation.
Whereas the proliferative defects that aff lict nfkb1/ and
c-rel/B cells result in part from a cell cycle block in late G1 that
occurs after the mitogen-induced increase in cell size, mitogen-
treated nfkb1/c-rel/ B cells fail to undergo enlargement.
This finding implicates the Rel/NF-B signaling pathway in the
control of mitogen-induced cell growth. Together with previous
work (15), it also establishes that in B cells, NF-B1 and c-Rel
regulate a number of distinct steps within the G1 phase of the cell
cycle. This combined role for NF-B1 and c-Rel dimers in
growth control within the B lineage appears to be restricted to
mature cells, as the growth of nfkb1/c-rel/ B cell progenitors
is normal (unpublished results). Whereas growth is intimately
linked with the increase in RNA and protein synthesis that
precedes DNA replication, little is known about the key molec-
ular regulators of growth in mammalian cells. Additional studies
are needed to identify the target genes regulated by RelNF-B
that are important for B cell growth.
Fig. 5. Antibody production and germ-line CH gene expression in nfkb1/c-rel/ mice. (A) Serum Ig levels in naive mice. Levels of serum Igs (gml) in naive
8- to 10-week-old litter-matched mice was determined by isotype-specific ELISA. Filled, hatched, empty, and stippled bars correspond to wild-type, nfkb1/,
c-rel/, and nfkb1/c-rel/ mice, respectively. Five mice of each genotype were examined. IgG1 levels were below the level of detection (ND) in nfkb1/c-rel/
mice. (B) Humoral response to NP-KLH. Five age-matched mice of each genotype were immunized with NP-KLH and serum samples were collected after 21 days.
The concentration (gml) of NP-specific IgG1 is indicated for wild-type (filled bars), nfkb1/ (hatched bars), and c-rel/ (empty bars) mice. Antigen-specific
IgG1 was below the levels of detection (ND) in nfkb1/c-rel/mice. (C) Germ-line CH transcript expression. RNA isolated from equal numbers of wild-type (lane 1),
nfkb1/ (lane 2), c-rel/ (lane 3), and nfkb1/c-rel/ (lane 4), B cells stimulated in culture for 6 h with various mitogen plus cytokine combinations (13) was
subjected to semiquantitative reverse transcription–PCR using primers specific for C3, C1, C, and C germ-line RNAs and -actin mRNA as a control. The PCR
products were then fractionated on agarose gels. B cells were stimulated with LPS alone (C3 RNA), LPS plus IL-4 (C1,C RNA), and LPS plus transforming growth
factor  (C RNA).
Fig. 6. Germinal centers do not form in nfkb1/c-rel/ mice. Sections of
spleens from wild-type, nfkb1/, c-rel/, and nfkb1/c-rel/ mice 14 days
postimmunization with NP-KLH were stained with horseradish peroxidase-
labeled B220 and biotinylated PNA. Follicles (F) and germinal centers (arrows)
are indicated (100 magnification). The stained sections shown are represen-
tative of mice of each genotype.
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The results presented here establish that the functions of c-Rel
and NF-B1 in the control of humoral immunity partially
overlap. In naı¨ve nfkb1/c-rel/ mice, all serum Igs are further
reduced compared with already abnormally low levels seen in the
nfkb1/ or c-rel/ mutants. The marked drop in serum IgM is
particularly interesting, given the finding that CD5 B cells,
which are thought to be a major source of secreted IgM (27, 28),
are greatly reduced in nfkb1/c-rel/ mice. Similarly, in re-
sponse to antigenic challenge, NP-specific antibodies, which
were reduced in nfkb1/ and c-rel/ mice, were undetectable
in the double mutants. Coupled with the drop in serum Igs, the
absence of germinal center B cells in nfkb1/c-rel/ mice
indicates that affinity maturation of antigen-specific humoral
responses is also unlikely. Impaired humoral immunity observed
in nfkb1/c-rel/ mice most likely reflects defects in both the
B cell and non-B cell compartments of the immune system.
Certainly B cell intrinsic defects such as cell division (29) and CH
germ-line gene transcription (30) will impact isotype switching.
However, the extent to which the disrupted architecture of
secondary lymphoid organs, coupled with defects in the function
of nfkb1/c-rel/ T cells (31) and antigen-presenting cells (32),
accounts for impaired humoral immunity is unclear and will
need to be addressed by reconstitution experiments using various
combinations of different wild-type and mutant cells. Finally, the
generation and characterization of mice lacking multiple mem-
bers of the RelNF-B family, in addition to revealing interactive
roles served by these transcription factors, offers an opportunity
to identify relevant target genes whose impaired expression can
account for the increasingly complex phenotypes observed in
these mutant mice.
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Fig. 7. Roles of RelNF-B proteins during B cell development and activation. The functions of different RelNF-B proteins within the B cell lineage were
deduced from the phenotype of single and multiple combinations of null mutations for these proteins.
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